Cello Health BioConsulting
  • menu
  • Home
  • About us
    • Mission, Vision & Values
    • Our Team
    • Why We’re Different
  • Capabilities
    • Common Client Dilemmas
    • Market Access Strategy
    • Opportunity Assessments
    • Opportunity Search and Evaluation
    • Portfolio and Platform Strategy
  • Our Insights
    • News
    • Presentations
    • Testimonials
    • Events
  • Careers
    • A Day in the Life
    • Current Opportunities
    • Our Culture
Heptares Co-founder and CSO, Fiona Marshall, Receives 2017 John Daly Lecture Award in Recognition of her Outstanding Contribution to GPCR Drug Discovery

Heptares Co-founder and CSO, Fiona Marshall, Receives 2017 John Daly Lecture Award in Recognition of her Outstanding Contribution to GPCR Drug Discovery

View Article +

GlycoMimetics stock rockets up on the latest ‘breakthrough’ title in cancer R&D

GlycoMimetics stock rockets up on the latest ‘breakthrough’ title in cancer R&D

View Article +

Molecular Partners’ strategic partner Allergan completed patient recruitment in both abicipar pegol nAMD Phase 3 studies

Molecular Partners’ strategic partner Allergan completed patient recruitment in both abicipar pegol nAMD Phase 3 studies

View Article +

Poxel Announces Positive Top Line Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes

Poxel Announces Positive Top Line Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes

View Article +

MorphoSys AG Reports Solid First Quarter 2017

MorphoSys AG Reports Solid First Quarter 2017

View Article +

Nanobiotix Expands Its Clinical Development In Head And Neck Cancer And Immuno-Oncology New Clinical Data To Be Presented At Asco

Nanobiotix Expands Its Clinical Development In Head And Neck Cancer And Immuno-Oncology New Clinical Data To Be Presented At Asco

Download PDF +

MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes

MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes

View Article +

Pieris Pharmaceuticals Appoints Claude Knopf As Chief Business Officer

Pieris Pharmaceuticals Appoints Claude Knopf As Chief Business Officer

View Article +

MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in Psoriatic Arthritis

MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in Psoriatic Arthritis

View Article +

Pieris Pharmaceuticals To Receive Glp Tox Milestone Payment In Daiichi Sankyo Collaboration

Pieris Pharmaceuticals To Receive Glp Tox Milestone Payment In Daiichi Sankyo Collaboration

View Article +

  1. ←
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. →

Search

Elsewhere

Let’s work together

Contact us

  • Cello Health BioConsulting
  • 25-B Hanover Road
  • Suite 320
  • Florham Park, NJ
  • 07932
  • USA
  • +1 973 292 5001
  •  
  • Part of Cello Health plc

Follow us

Cello Health BioConsulting

©2019 Defined Health, now known as Cello Health BioConsulting | Privacy policy.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Defined Health, now known as Cello Health BioConsulting

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

You can adjust all of your cookie settings by navigating the tabs on the left hand side.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!